🇺🇸 FDA
Patent

US 8628962

Differentiation of stem cells into dopaminergic cells

granted A61PA61P25/16A61P25/28

Quick answer

US patent 8628962 (Differentiation of stem cells into dopaminergic cells) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P25/16, A61P25/28